Senestech (SNES)
(Real Time Quote from BATS)
$0.71 USD
+0.04 (6.14%)
Updated May 16, 2024 03:49 PM ET
After-Market: $0.71 0.00 (0.00%) 4:10 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Senestech, Inc. [SNES]
Reports for Purchase
Showing records 21 - 40 ( 58 total )
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: GILSON I
Company: Senestech, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Senestech, Inc.
Industry: Medical - Products
Building Sales Efforts; Adding Value Through Regulatory Efforts
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Company: Senestech, Inc.
Industry: Medical - Products
Label Restriction Update Eases Sales Friction
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Company: Senestech, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Senestech, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Senestech, Inc.
Industry: Unclassified
Company: Senestech, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Senestech, Inc.
Industry: Unclassified
Regulatory Road Map Announcement - A Marketing - Strategic Move
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Company: Senestech, Inc.
Industry: Unclassified
California Approves ContraPest; Estimate Updates for 1Q18
Provider: Roth Capital Partners, Inc.
Analyst: SWEENEY G
Company: Senestech, Inc.
Industry: Unclassified
Company: Senestech, Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Senestech, Inc.
Industry: Unclassified
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.